The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pneumonitis (ILD)
Publications
Cyclophosphamide-Induced Lung Injury.
Kidney international reports 2019 Mar;4;484-486 — 2019 Mar — 484-486
[Cyclophosphamide-induced interstitial pneumopathy. Course data of bronchoalveolar lavage apropos of a case and review of the literature].
Revue de pneumologie clinique 1999 Apr;55;100-4 — 1999 Apr — 100-4
Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
American journal of respiratory and critical care medicine 1996 Dec;154;1851-6 — 1996 Dec — 1851-6
A case of cyclophosphamide-induced interstitial pneumonitis diagnosed by bronchoalveolar lavage.
Respiration; international review of thoracic diseases 1992;59;125-8 — 1992 — 125-8